Table 2 Pooled prevalence of E. faecium and E. faecium among enterococci, their Vancomycin resistance and VanA and VanB genes among VRE
Group | Included studies | Total number of enterococci | Pooled prevalence(%) and 95% CI | I2 Heterogeneity | Heterogeneity test, P value | Publication bias testing | |
|---|---|---|---|---|---|---|---|
Egger’s test | Begg’s test | ||||||
E. faecium among total enterococci | 20 | 1357 | 32.47 (27 to 38.2) | 79.47% | P < 0.0001 | P = 0.2349 | P = 0.3132 |
E. faecalis among total enterococci | 20 | 1357 | 61.22 (53.65 to 68.53) | 87.58% | P < 0.0001 | P = 0.3485 | P = 0.5803 |
Vancomycin-resistant E. faecium among total E. faecium | 12 | 266 | 46.1 (25.7 to 67.1) | 79.86% | P < 0.0001 | P = 0.0612 | P = 0.1120 |
Vancomycin-resistant E. faecalis among total E. faecalis | 13 | 453 | 31.7 (18.6 to 46.4) | 90.53% | P < 0.0001 | P = 0.0091 | P = 0.0316 |
VanA among VRE | 7 | 192 | 63.3 (52.1 to 73.7) | 57.61% | P = 0.0280 | N/Pa | N/P |
VanB genes among VRE | 7 | 192 | 17.95 (7.8 to 31) | 77.29% | P = 0.0002 | N/P | N/P |